Retail

How fast is the UK Food Standards Agency (FSA) novel food application validation process moving?

22nd April 2021 - Blogs |

It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in early January. Both also are at least partly based on synthetic CBD ingredients that have successfully navigated EU novel food application initial » Continue Reading.

Is delta-8 THC really the next big thing?

14th April 2021 - Blogs |

From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of interest from companies and consumers alike. The appeal appears to be that it acts as a “lighter” version of delta-9 THC – the more typical psychoactive element » Continue Reading.

What impact will the EC’s decision to permit the use of extracts from the whole plant in cosmetics have on the industry as a whole?

28th January 2021 - Blogs |

The decision – which should be noted is still only preliminary, though almost certainly to be confirmed with subsequent updating of the cosmetics ingredients (CosIng) database – should allow a wider range of cosmetic products onto the market. Exactly how much of an impact the change – when it eventually is confirmed – will make in reality largely depends on » Continue Reading.

Is the entrance of British American Tobacco (BAT) into the CBD sector a positive or negative for the industry?

22nd January 2021 - Blogs |

The top-line answer is that it is wholly neither. There are elements of both in any position taken on the news. BAT’s entrance into the market with its vaping product under the Vuse brand (coming in three flavours – mint, mango and berry – and two strengths – 50 mg at £9.99 and 100 mg at £14.99) would be priced at the higher end of » Continue Reading.

Do CBD firms expect much of a January uptick in sales?

18th December 2020 - Blogs |

It seems many of the firms CBD-Intel has talked to see a similar story for January sales, focused on resolutions or upticks in health and wellness – as was predicted for the holidays sales period stretching from Black Friday at the end of November into the gift-giving Christmas and other holidays period through December. Overall, the market is still too » Continue Reading.

Topicals report, Q1 2020

16th July 2020 - Market reports |

This report addresses the evolution of the topicals category and the common characteristics and main differences between eight European countries and the US, covering product segmentation and pricing

Could subscription services boost CBD sales during times of restricted offline retail and social distancing?

18th June 2020 - Blogs |

Subscription services do offer potential benefits to CBD companies. Those benefits come with risks, which may be managed. But the key question for anyone interested in creating such a service is whether they prefer to market to early adopters that have done their research and know what products they want or to consumers with limited CBD knowledge in order to give them the chance to try products they may otherwise have overlooked.